PNC Financial Services Group’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-27
Closed -$358 – 5422
2026
Q2
$358 Buy
27
+22
+440% +$491 ﹤0.01% 5040
2026
Q1
$133 Buy
5
+3
+150% +$377 ﹤0.01% 5079
2025
Q4
$617 Sell
2
-2
-50% -$457 ﹤0.01% 4793
2025
Q3
$760 Buy
+4
New +$705 ﹤0.01% 4729
2022
Q4
– Hold
0
– – – 4802
2022
Q3
– Hold
0
– – – 4512
2022
Q1
– Sell
-3
Closed -$2K – 4593
2021
Q4
$2K Sell
3
-2
-40% -$1.9K ﹤0.01% 4159
2021
Q3
$6K Buy
+5
New +$3.68K ﹤0.01% 3881

Other funds holding GOSS

PNC Financial Services Group's GOSS Position: Q3 2026 in Review

PNC Financial Services Group sold out of Gossamer Bio (GOSS) in Q3 2026, closing a stake of 27 shares — an estimated $358 sold.

PNC Financial Services Group first reported a position in GOSS in Q3 2021 and held it in 6 quarters. The position peaked at $6K in Q3 2021. 76 funds tracked by Wall St. Rank hold GOSS as of Q3 2026.

  • PNC Financial Services Group reported no remaining Gossamer Bio position as of Q3 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 27 Gossamer Bio shares in Q3 2026, an estimated $358.
  • PNC Financial Services Group first reported a position in Gossamer Bio in Q3 2021 and held it in 6 quarters.
  • PNC Financial Services Group's Gossamer Bio position peaked at $6K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Gossamer Bio as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.